REQUEST A DEMO
Total
USD $0.00
Search more companies

Exel Medical Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Exel Medical Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Exel Medical Sas is an enterprise in Colombia, with the main office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Exel Medical Sas was incorporated on January 05, 2007. It currently has a total number of 28 (2024) employees. There was a net sales revenue increase of 39.57% reported in Exel Medical Sas’s latest financial highlights for 2023. Its’ total assets recorded a growth of 14.27%. In 2023, Exel Medical Sas’s net profit margin increased by 1.61%.

Headquarters
Calle 147 # 17-78 Ofc 604-606 Edificio Soko147
Bogota D.C.; Bogota D.C; Postal Code: 1021

Contact Details: Purchase the Exel Medical Sas report to view the information.

Basic Information
Total Employees:
Purchase the Exel Medical Sas report to view the information.
Outstanding Shares:
Purchase the Exel Medical Sas report to view the information.
Incorporation Date:
January 05, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
33.33%
Company Performance
Financial values in the chart are available after Exel Medical Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
39.57%
Total operating revenue
39.57%
Operating profit (EBIT)
41.84%
Net Profit (Loss) for the Period
71.34%
Total assets
14.27%
Total equity
39.87%
Operating Profit Margin (ROS)
0.23%
Net Profit Margin
1.61%
Return on Equity (ROE)
3.83%
Quick Ratio
0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?